A Phase 2 Open-label Study of the Effect of Adjunctively administered ABX-002 on Brain Bioenergetics in Adults with Bipolar Disorder Experiencing an Episode of Depression
Brief description of study
The main purpose of this study is to learn how ABX-002 affects brain processing and symptoms of depression by using brain imaging called techniques called Magnetic Resonance Spectroscopy (MRS) and functional Magnetic Resonance Imaging (fMRI). NYU Langone Health is recruiting healthy volunteers to participate. Participants in this group will not be given the study drug.
Clinical Study Identifier: s24-01910
ClinicalTrials.gov Identifier: NCT06869187
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.
